Browsing by author "Sanz, Guillermo"

Repository

How to publish

Resources

FAQs

Now showing items 1-6 of 6

Clinical and biological characterization of low risk MDS patients according to ring sideroblasts (RS). Comparison between the 3 subgroups in WHO2017 classification. Study from the Spanish MDS registry

López Cadenas, Félix; Bernal del Castillo, Teresa; Sanz, Guillermo (2021)
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply

Bernal del Castillo, Teresa; Martínez Camblor, Pablo; Sánchez García, Joaquín; Sanz, Guillermo (2016)
Expression of APO2. 7, bcl-2 and bax apoptosis-associated proteins in CD34− bone marrow cell compartments from patients with myelodysplastic syndromes

Suarez, L; Sanz, Guillermo; Lopez, A; Lopez-Berges, MC; de Santiago, M; Palomera, L; Bernal, T; Perez de Equiza, ME; San Miguel, MF; Orfao, A (2004-07)
Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes

Senent, Leonor; Arenillas, Leonor; Luño Fernández, Elisa; Ruiz, Juan C.; Sanz, Guillermo; Florensa Brichs, Lourdes; Spanish MDS Cooperat Grp GESMD (Ferrrata Storti Foundation, 2013)
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low

Valcárcel Ferreiras, David; Sanz, Guillermo; Ortega, Margarita; Nomdedeu, Benet; Luño Fernández, Elisa; Díez Campelo, María; Ardanaz, María Teresa; Pedro, Carme; Montoro, Julia; Collado, Rosa; Andreu, Rafael; Marco, Víctor; Cedena, María Teresa; Tormo, Mar; Brunet, Salut; Muñoz, Juan Antonio; Gómez, Valle; Bailén, Alicia; Sánchez García, Joaquín; Merchán, Brayan; Cañizo, Consuelo del; Vallespí, Teresa; Bargay, Joan; González, Bernardo; Xicoy, Blanca (Elsevier, 2015)
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

Swart, L. de; Smith, Alex; Johnston, T. W.; Haase, D.; Droste, J.; Fenaux, P.; Symeonidis, Argiris; Sanz, Guillermo; Hellström Lindberg, E.; Luño Fernández, Elisa (Wiley, 2015)

Browsing by author "Sanz, Guillermo"

Clinical and biological characterization of low risk MDS patients according to ring sideroblasts (RS). Comparison between the 3 subgroups in WHO2017 classification. Study from the Spanish MDS registry ﻿

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply ﻿

Expression of APO2. 7, bcl-2 and bax apoptosis-associated proteins in CD34− bone marrow cell compartments from patients with myelodysplastic syndromes ﻿

Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes ﻿

Use of newer prognostic indices for patients with myelodysplastic syndromes in the low ﻿

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry ﻿

Clinical and biological characterization of low risk MDS patients according to ring sideroblasts (RS). Comparison between the 3 subgroups in WHO2017 classification. Study from the Spanish MDS registry

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply

Expression of APO2. 7, bcl-2 and bax apoptosis-associated proteins in CD34− bone marrow cell compartments from patients with myelodysplastic syndromes

Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes

Use of newer prognostic indices for patients with myelodysplastic syndromes in the low

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry